CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 41 enrolled
Drug / intervention
Insulin lispro A +1 moredrug
Likely dose
Insulin lispro A 20 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01133392
NCT01133392Phase 1Completed
CompareCT.gov

Evaluation of the Bioequivalence of Two Formulations of Insulin Lispro in Healthy Subjects

Eli Lilly and Company·interventional·Posted May 28, 2010·Updated Dec 30, 2014

In Brief

A Phase 1 clinical trial evaluating Insulin lispro A and Insulin lispro B for Healthy Volunteers. Completed, enrolled 41 participants across 1 site.

Detailed Summary

This study will compare how the body treats 2 different forms of insulin lispro and how they affect blood sugar levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesSingapore
Collaborators--

Timeline

Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 28, 2010
Enrollment StartMay 1, 2010
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.1 years ago

Interventions

Insulin lispro Adrug

20 units (U) subcutaneously (SC).

Insulin lispro Bdrug

20 U subcutaneously (SC).